StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
Publishing Date
2022 - 03 - 10
1
2021 - 12 - 13
2
2021 - 11 - 04
1
2021 - 09 - 08
1
2021 - 07 - 21
1
2021 - 06 - 04
1
2021 - 03 - 03
1
2021 - 02 - 10
1
Sector
Health technology
9
Tags
Abbvie
77
Active
14
Aesthetic
22
Alliances
19
America
42
Antibody
17
Application
15
Approval
37
Atopic dermatitis
10
Biomidwest
43
Biotech-beach
10
Business
12
Cancer
53
Cd20
13
Chmp
10
Clinical-trials-phase-iii
26
Collaboration
23
Conference
32
Contract
13
Deadline
11
Dermatitis
14
Disease
65
Drug
75
Duobody
13
Earnings
22
Europe
16
Events
24
Expected
18
Eye
17
Fda
42
Financial
26
Financial results
12
Genetown
11
Global
113
Growing
24
Growth
174
Health
20
Leukemia
16
Market
383
Meeting
12
Migraine
23
N/a
783
Pharma
17
Pharmaceuticals
11
Phase 3
30
Positive
31
Reach
16
Report
97
Research
81
Results
80
Rinvoq
28
Risankizumab
14
Set
15
Skyrizi
16
Therapeutics
88
Therapy
40
Treatment
117
Trial
32
Ulcerative colitis
14
Year
12
Entities
Abbvie inc.
9
Assembly biosciences, inc.
2
Beigene, ltd.
1
Coherus biosciences, inc.
6
Symbols
AADI
53
ABBV
9
AKYA
15
ANIX
20
ANNX
10
APVO
28
ARTL
22
ASMB
24
BAX
7
CALA
11
CDAK
12
CHRS
41
COGT
18
CSTL
39
CTKB
10
DARE
90
DRUG
6
DTIL
34
ELAN
5
ENOB
9
ENSC
14
ENVB
28
EVFM
33
EVLO
33
FNCTF
7
GILD
10
HBIO
33
HRMY
31
IDXG
14
IDYA
21
IGMS
24
INVO
43
JNJ
16
LEXX
8
LLY
10
LMNL
14
MS
20
MSCLF
29
NBIX
18
PACB
22
PBIO
6
PCRX
25
PLSE
25
RCUS
8
REVB
6
RGC
13
RKDA
29
RNA
17
RXDX
13
SELB
25
SKYE
52
SLDB
22
SNY
18
SNYNF
16
SPRB
9
TWST
155
VIVO
38
XBIO
21
YTEN
61
ZIVO
9
Exchanges
Nasdaq
8
Nyse
9
Crawled Date
2022 - 03 - 12
1
2021 - 12 - 13
2
2021 - 11 - 05
1
2021 - 09 - 08
1
2021 - 07 - 21
1
2021 - 06 - 04
1
2021 - 03 - 03
1
2021 - 02 - 10
1
Crawled Time
12:00
1
14:00
3
16:00
1
16:20
1
18:00
1
21:00
1
22:00
1
Source
investor.assemblybio.com
2
www.biospace.com
2
www.globenewswire.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Bioscience
symbols :
Abbv
save search
Assembly Biosciences Reports Fourth Quarter and Year End 2021 Financial Results and Recent Highlights
Published:
2022-03-10
(Crawled : 16:20)
- investor.assemblybio.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.48%
|
O:
1.15%
H:
0.0%
C:
0.0%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-27.51%
|
O:
3.43%
H:
0.0%
C:
0.0%
ASMB
|
$13.64
2.33%
2.27%
11K
|
Health Technology
|
776.47%
|
O:
-0.33%
H:
0.0%
C:
0.0%
financial results
report
bioscience
results
Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
Published:
2021-12-13
(Crawled : 21:00)
- globenewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
34.34%
|
O:
1.07%
H:
0.0%
C:
0.0%
CHRS
|
$2.06
3.0%
2.91%
2.9M
|
Health Technology
|
-87.69%
|
O:
-0.83%
H:
0.0%
C:
0.0%
hoice-01
treatment
trial
lung cancer
positive
therapy
bioscience
results
cancer
phase 3
Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01
Published:
2021-12-13
(Crawled : 18:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
34.34%
|
O:
1.07%
H:
0.0%
C:
0.0%
CHRS
|
$2.06
3.0%
2.91%
2.9M
|
Health Technology
|
-87.69%
|
O:
-0.83%
H:
0.0%
C:
0.0%
hoice-01
positive
bioscience
results
Assembly Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights
Published:
2021-11-04
(Crawled : 16:00)
- investor.assemblybio.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
42.16%
|
O:
-0.28%
H:
0.51%
C:
0.39%
ASMB
|
$13.64
2.33%
2.27%
11K
|
Health Technology
|
323.03%
|
O:
0.0%
H:
1.58%
C:
-1.89%
financial results
results
bioscience
Coherus BioSciences Announces Upcoming Medical Conference Presentations
Published:
2021-09-08
(Crawled : 14:00)
- globenewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
52.63%
|
O:
-0.89%
H:
2.63%
C:
2.13%
CHRS
|
$2.06
3.0%
2.91%
2.9M
|
Health Technology
|
-86.27%
|
O:
0.46%
H:
3.23%
C:
3.23%
presentation
conference
bioscience
Coherus BioSciences Names Physician-Scientist Ildiko Csiki, M.D., Ph.D., Chair of its Scientific Advisory Board
Published:
2021-07-21
(Crawled : 14:00)
- globenewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
43.4%
|
O:
0.51%
H:
0.37%
C:
0.3%
CHRS
|
$2.06
3.0%
2.91%
2.9M
|
Health Technology
|
-84.23%
|
O:
-0.08%
H:
3.28%
C:
0.0%
bioscience
Coherus and Junshi Biosciences to Host Virtual Investor Event to Discuss Toripalimab and ASCO 2021 Highlights
Published:
2021-06-04
(Crawled : 22:00)
- globenewswire.com
CHRS
|
$2.06
3.0%
2.91%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
bioscience
Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma
Published:
2021-03-03
(Crawled : 12:00)
- globenewswire.com
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
54.3%
|
O:
-0.92%
H:
0.26%
C:
-0.14%
CHRS
|
$2.06
3.0%
2.91%
2.9M
|
Health Technology
|
-86.84%
|
O:
0.95%
H:
1.32%
C:
-2.83%
treatment
fda
submission
bioscience
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
Published:
2021-02-10
(Crawled : 14:00)
- biospace.com/
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
57.88%
|
O:
0.55%
H:
0.14%
C:
-1.82%
collaboration
car-t
license
t-cell
announces collaboration
bioscience
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.